Geraldine Henwood, President and CEO at Recro Pharma, Inc. (REPH), sold 80,000 shares at $8.22 ($658K) on 2020-04-17, disclosed to the SEC on 2020-04-20.
Open-market sale of $658k REPH by President and CEO. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| BXRX | BUY | 2021-05-10 | $5K | — | Filing → |
| REPH | SELL | 2019-05-15 | $1.5M | — | Filing → |
| REPH | BUY | 2015-06-09 | $40K | — | Filing → |